CRISPR Gene Editing: The First Therapy Approved The world of medicine has witnessed a groundbreaking milestone with the approval of the first CRISPR-based gene therapy, Casgevy, by the U.S. Food and Drug Administration (FDA). This revolutionary treatment holds the potential to cure sickle cell disease and beta-thalassemia, two debilitating genetic disorders that have long plagued … Continue reading CRISPR Gene Editing: The First Therapy Approved More